Funding Details
- Awarder
- Inbox
- Date Award
- May 28, 2025
- Vertical
- Techbio
- Funding URL
- View Funding Page
- Funding Amount:
-
$15,000,000
Company Info
- Traction
- Hedera Dx's tests are already being used in 11 European countries, establishing itself as a leading platform for precision oncology.
- Founders
- Tommi Lehtonen, Christian Meisel
- Company Description
- A diagnostics platform that makes liquid biopsies a reality in cancer care
- Market
- Precision Oncology
- Location
-
Vaud,
Switzerland
- Coinvestors
- Vsquared Ventures, Tesi, Helsana HealthInvest, Eyrir Venture Management, Inventure, Top Harvest
Links